Overview

Study of MRA in Patients With Rheumatoid Arthritis (RA)

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
This is an open-label, extension, Phase II study to evaluate the long-term safety and efficacy of MRA in Patients with RA who were participated in Study MRA009JP.
Phase:
Phase 2
Details
Lead Sponsor:
Chugai Pharmaceutical